教職

國防醫學院醫學系放射腫瘤學科臨床講師 2013年8月～迄今
教育部 部定講師 2017年8月～迄今

經歷

三軍總醫院放射腫瘤部住院醫師 2013年8月～2016年7月
三軍總醫院放射腫瘤部總住院醫師 2016年8月～2017年7月
三軍總醫院放射腫瘤部資深住院醫師 2017年8月～2018年3月
三軍總醫院放射腫瘤部主治醫師 2018年4月～ ～迄今

專長學科

放射腫瘤學
肺癌、乳癌、消化道癌、泌尿道癌、骨腫瘤及軟組織肉瘤等腫瘤放射治療
影像導引放射治療
立體定位放射治療

論文發表

1. Yang JF, Lo CH, Lee MS, Lin CS, Dai YH, Shen PC, Chao HL, Huang WY. Stereotactic Ablative Radiotherapy versus Conventionally Fractionated Radiotherapy in the treatment of Hepatocellular Carcinoma with Portal Vein Invasion: a Restrospective Analysis. Radiat Oncol. 2019 Oct 22;14(1):180.

2. Yang JF, Lee MS, Lin CS, Chao HL, Chen CM, Lo CH, Fan CY, Tsao CC, Huang WY. Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy. Medicine (Baltimore). 2016 Mar;95(11):e3113.

3. Yang JF, Lo CH, Huang WY. Is Stereotactic Body Radiotherapy Better Than Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma? J Clin Oncol. 2016 Aug 10;34(23):2797.

4. Yang JF, Lo CH, Lin CS, Chao HL, Lin KT, Chen CM, Huang WY. Factors associated with radiographic response and overall survival after stereotactic ablative radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Therapeut Radiol Oncol. 2017 Mar; 24(1): 13-23

5. Shen PC, Chang WC, Lo CH, Yang JF, Lee MS, Dai YH, Lin CS, Fan CY, Huang WY*. Comparison of stereotactic body radiotherapy and transarterial chemoembolization for unresectable medium-sized hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2019;105(2):307-318

6. Lo CH, Huang WY, Hsiang CW, Lee MS, Lin CS, Yang JF, Hsu HH, Chang WC. Prognostic significance of apparent diffusion coefficient in hepatocellular carcinoma patients treated with stereotactic ablative radiotherapy. Sci Rep 2019;9:14157.

7. Lo CH, Liu MY, Lee MS, Yang JF, Jen YM, Lin CS, Chao HL, Shen PC, Huang WY. Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):145-152.

8. Lo CH, Yang JF, Liu MY, Jen YM, Lin CS, Chao HL, Huang WY. Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy. PLoS One. 2017 May 17;12(5):e0177793.

9. Fan CY, Huang WY, Lin KT, Lin CS, Chao HL, Yang JF, Lin CL, Kao CH. Lower Urinary Tract Infection and Subsequent Risk of Prostate Cancer: A Nationwide Population-Based Cohort Study. PLoS One. 2017 Jan 3;12(1):e0168254.

10. Huang WY, Ho CL, Lee CC, Hsiao CW, Wu CC, Jao SW, Yang JF, Lo CH, Chen JH. Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer. PLoS One. 2017 Mar 22;12(3):e0174280.

11. Liu MY, Lo CH, Lin CS, Chao HL, Yang JF, Lin KT, Fan CY, Su YF, Huang WY. Stereotactic ablative radiotherapy for patients with unresectable or medically inoperable cholangiocarcinoma. Tumori. 2017 Jan 5:0.